When a recent mini campaign planning study at Harvard T.H. Chan’s School of Public Health was forced to go completely virtual during the first weeks of the COVID-19 crisis, there were lessons to be learned.
In this webinar, GG+A Senior Vice President Andrew Allred and Harvard Chan’s Vice Dean of the Office for External Relations Kristen Rozansky discuss the pros, cons, lesson learned and implications for how they feel this might change the future of campaign planning studies.
The campaign planning study for the Human Immunomics Initiative came about coincidentally just as the COVID-19 pandemic began and vaccine development entered the global spotlight.
The joint project by Harvard Chan and the Human Vaccines Project “aims to revolutionize the understanding of the human immune system and accelerate the creation of effective vaccines, diagnostics, and treatments,” according to Harvard Chan.
“The importance of doing the study became even more clear as we entered into the pandemic,” says Kristen Rozansky in the webinar, “because it gave us a way to connect with our top prospects and donors, and really bring them into a very important conversation about an important initiative. It became this opportunity to really engage those closest to us.”
Watch the webinar below to learn more about what the decision to go virtual with the study meant, and what routes were pursued when the traditional mechanisms of gauging a campaign’s feasibility could not be pursued.